Fani Pujol-Calderón1, Erik Portelius2, Henrik Zetterberg3, Kaj Blennow2, Lars E Rosengren4, Kina Höglund2. 1. Department of Psychiatry & Neurochemistry, University of Gothenburg, Sweden. Electronic address: fani.pujol-calderon@neuro.gu.se. 2. Department of Psychiatry & Neurochemistry, University of Gothenburg, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. 3. Department of Psychiatry & Neurochemistry, University of Gothenburg, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, United Kingdom; UK Dementia Research Institute at UCL, London, United Kingdom. 4. Institute of Neuroscience and Physiology, Department of Clinical Neuroscience and Rehabilitation, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Abstract
BACKGROUND: Neurofilament light (NFL) is a well-validated biomarker for neuronal injury and neurodegeneration. Increased cerebrospinal fluid (CSF) levels have been shown after stroke, as well as in patients with a broad range of neurodegenerative and neuroinflammatory diseases. Neurofilament heavy (NFH) belongs to the same family of structural proteins but it is less extensively studied. The potential of phosphorylated NFH (pNFH) as a stroke biomarker and for the prediction of clinical outcome is unknown. In this study, we aimed to examine the temporal pattern of NFL and pNFH concentrations in serum and CSF after acute ischemic stroke. MATERIALS AND METHODS: A quantitative Enzyme-Linked ImmunoSorbent Assay (ELISA) for pNFH was developed and tested on CSF and serum samples. NFL and pNFH were analysed in serum and CSF of acute ischemic stroke patients, who were followed over time (Day 0-1, Day 2-3, Day 7-9, three weeks, and 3-5 months after stroke). RESULTS: NFL and pNFH concentrations in serum and CSF increased after stroke, peaked during the 3rd week, and then decreased back to almost baseline levels at 3-5 months. CSF-NFL and serum-NFL correlated to the outcome measured by Barthel Index after 3-5 months, whilst no such association was seen for pNFH. DISCUSSION: These findings suggest that NFL and pNFH in both CSF and serum reflect the temporal pattern of the post ischemic axonal injury and that this process does not seem to progress after 3-5 months. CONCLUSION: NFL and pNFH in CSF and serum are promising biomarkers for axonal injury following stroke. Further studies in larger populations are needed to fully understand the progression of the neuronal damage after acute ischemic stroke and to evaluate if these biomarkers can provide additive information and how they relate to outcome.
BACKGROUND: Neurofilament light (NFL) is a well-validated biomarker for neuronal injury and neurodegeneration. Increased cerebrospinal fluid (CSF) levels have been shown after stroke, as well as in patients with a broad range of neurodegenerative and neuroinflammatory diseases. Neurofilament heavy (NFH) belongs to the same family of structural proteins but it is less extensively studied. The potential of phosphorylated NFH (pNFH) as a stroke biomarker and for the prediction of clinical outcome is unknown. In this study, we aimed to examine the temporal pattern of NFL and pNFH concentrations in serum and CSF after acute ischemic stroke. MATERIALS AND METHODS: A quantitative Enzyme-Linked ImmunoSorbent Assay (ELISA) for pNFH was developed and tested on CSF and serum samples. NFL and pNFH were analysed in serum and CSF of acute ischemic strokepatients, who were followed over time (Day 0-1, Day 2-3, Day 7-9, three weeks, and 3-5 months after stroke). RESULTS:NFL and pNFH concentrations in serum and CSF increased after stroke, peaked during the 3rd week, and then decreased back to almost baseline levels at 3-5 months. CSF-NFL and serum-NFL correlated to the outcome measured by Barthel Index after 3-5 months, whilst no such association was seen for pNFH. DISCUSSION: These findings suggest that NFL and pNFH in both CSF and serum reflect the temporal pattern of the post ischemic axonal injury and that this process does not seem to progress after 3-5 months. CONCLUSION:NFL and pNFH in CSF and serum are promising biomarkers for axonal injury following stroke. Further studies in larger populations are needed to fully understand the progression of the neuronal damage after acute ischemic stroke and to evaluate if these biomarkers can provide additive information and how they relate to outcome.
Authors: Kristen Dams-O'Connor; Patrick S F Bellgowan; Roderick Corriveau; Mary Jo Pugh; Douglas H Smith; Julie A Schneider; Keith Whitaker; Henrik Zetterberg Journal: J Neurotrauma Date: 2021-12 Impact factor: 5.269
Authors: Maria Boge Lauvsnes; Henrik Zetterberg; Kaj Blennow; Jan Terje Kvaløy; Anne Bolette Tjensvoll; Stian Maroni; Mona K Beyer; Ole Jacob Greve; Ingeborg Kvivik; Guido Alves; Lasse Gunnar Gøransson; Erna Harboe; Shunsei Hirohata; Roald Omdal Journal: J Neurol Date: 2021-11-20 Impact factor: 4.849
Authors: Tania F Gendron; Mohammed K Badi; Michael G Heckman; Karen R Jansen-West; George K Vilanilam; Patrick W Johnson; Alexander R Burch; Ronald L Walton; Owen A Ross; Thomas G Brott; Timothy M Miller; James D Berry; Katharine A Nicholson; Zbigniew K Wszolek; Björn E Oskarsson; Kevin N Sheth; Lauren H Sansing; Guido J Falcone; Brett L Cucchiara; James F Meschia; Leonard Petrucelli Journal: Sci Transl Med Date: 2020-11-11 Impact factor: 19.319
Authors: Stephanie A Schultz; Jeremy F Strain; Adedamola Adedokun; Qing Wang; Oliver Preische; Jens Kuhle; Shaney Flores; Sarah Keefe; Aylin Dincer; Beau M Ances; Sarah B Berman; Adam M Brickman; David M Cash; Jasmeer Chhatwal; Carlos Cruchaga; Michael Ewers; Nick N Fox; Bernardino Ghetti; Alison Goate; Neill R Graff-Radford; Jason J Hassenstab; Russ Hornbeck; Clifford Jack; Keith Johnson; Nelly Joseph-Mathurin; Celeste M Karch; Robert A Koeppe; Athene K W Lee; Johannes Levin; Colin Masters; Eric McDade; Richard J Perrin; Christopher C Rowe; Stephen Salloway; Andrew J Saykin; Reisa Sperling; Yi Su; Victor L Villemagne; Jonathan Vöglein; Michael Weiner; Chengjie Xiong; Anne M Fagan; John C Morris; Randall J Bateman; Tammie L S Benzinger; Mathias Jucker; Brian A Gordon Journal: Neurobiol Dis Date: 2020-06-06 Impact factor: 5.996